Breast Cancer Clinical Trial

Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors

Summary

This study aims to recruit post-treatment breast cancer survivors for a 12-week 2-arm randomized walking intervention. All intervention materials will be delivered electronically.

The investigators hypothesize that at the end of 12-weeks, participants randomized to the intervention group will engage in more weekly steps than those participants randomized to the comparison group.

View Full Description

Full Description

More than two-thirds of breast cancer survivors are physically inactive. Inactivity is known to negatively impact both morbidity and mortality, and is especially pronounced among cancer survivors. Self-directed interventions targeting inactivity among breast cancer survivors often report clinically insignificant behavior change. More successful behavior change interventions have suggested that tailoring and, more recently, the fostering of intrinsic motivation, may have improved outcomes. However, no interventions to date have utilized these approaches to increase physical activity among sedentary cancer survivors.

AIM 1: Develop and test intervention (tailored) and comparison group (targeted) messages in a sample of sedentary women to determine message acceptability.

AIM 2: Determine the efficacy of a 12-week tailored intervention to increase the number of weekly steps taken among sedentary post-treatment breast cancer survivors compared to a 12-week, targeted intervention.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
40-70 years of age
History of breast cancer stage I-II
2-10 years post-treatment
Sedentary
Technology access and skills
Regular access to personal computer/ broadband internet and email account
Comfortability using internet, and web-based tools
US Resident

Exclusion Criteria:

Concurrent enrollment in another physical activity/ lifestyle/ weight loss intervention program/study
Current secondary cancer diagnosis/ treatment
Inability to ambulate
Refusal to wear personal activity monitor (FitBit Ultra) for the duration of the study
Engaging in regular moderate to vigorous physical activity

Study is for people with:

Breast Cancer

Estimated Enrollment:

90

Study ID:

NCT01845519

Recruitment Status:

Completed

Sponsor:

Leanne Kaye

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Lineberger Comprehensive Cancer Center/ University of North Carolina
Chapel Hill North Carolina, 27599, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

90

Study ID:

NCT01845519

Recruitment Status:

Completed

Sponsor:


Leanne Kaye

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider